Serendex Pharmaceuticals

Copenhagen, Denmark Founded: 2008 • Age: 18 yrs Acquired By Savara Pharma
Pharmaceutical drug development company focusing on respiratory conditions
Request Access

About Serendex Pharmaceuticals

Serendex Pharmaceuticals is a company based in Copenhagen (Denmark) founded in 2008 was acquired by Savara Pharma in July 2016.. The company has 1 employees as of December 31, 2021. Serendex Pharmaceuticals operates in a competitive market with competitors including aTyr Pharma, ReCode Therapeutics, Enterprise Therapeutics, Ikaria and GEn1E, among others.

  • Headquarter Copenhagen, Denmark
  • Employees 1 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Serenova A/S
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    1

    as on Dec 31, 2021

  • Acquired by
    Savara Pharma

    (Jul 18, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Serendex Pharmaceuticals

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Serendex Pharmaceuticals

Serendex Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Savara Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Serendex Pharmaceuticals

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Serendex Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Serendex Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Serendex Pharmaceuticals

Serendex Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as aTyr Pharma, ReCode Therapeutics, Enterprise Therapeutics, Ikaria and GEn1E, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Protein biologics are developed for treating rare diseases.
domain founded_year HQ Location
Precision medicines for lung-related diseases are developed.
domain founded_year HQ Location
Developer of therapeutic solutions for the treatment of respiratory diseases such as cystic fibrosis
domain founded_year HQ Location
Therapies for respiratory-related cardiopulmonary disorders are developed.
domain founded_year HQ Location
Developer of therapeutics for the treatment of inflammatory and rare diseases
domain founded_year HQ Location
Developer of therapeutics for the treatment of respiratory diseases
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Serendex Pharmaceuticals

Frequently Asked Questions about Serendex Pharmaceuticals

When was Serendex Pharmaceuticals founded?

Serendex Pharmaceuticals was founded in 2008.

Where is Serendex Pharmaceuticals located?

Serendex Pharmaceuticals is headquartered in Copenhagen, Denmark.

How many employees does Serendex Pharmaceuticals have?

As of Dec 31, 2021, the latest employee count at Serendex Pharmaceuticals is 1.

What does Serendex Pharmaceuticals do?

Serendex Pharmaceuticals was founded in 2008 in Copenhagen, Denmark. Focus is placed on pharmaceutical drug development for pulmonary diseases and respiratory conditions. The pipeline includes GM-CSF targeted at pulmonary alveolar proteinosis in phase 2b3, acute respiratory distress syndrome in phase 2b, and bronchiectasis in phase 2a, though the bronchiectasis trial is currently on hold. Operations center on advancing clinical trials in this sector.

Who are the top competitors of Serendex Pharmaceuticals?

Serendex Pharmaceuticals's top competitors include aTyr Pharma, ReCode Therapeutics and Pulmatrix.

Who are Serendex Pharmaceuticals's investors?

Serendex Pharmaceuticals has 1 investor. Key investors include Savara Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available